CO2023018191A2 - Métodos de purificación de columnas de vectores de aav - Google Patents

Métodos de purificación de columnas de vectores de aav

Info

Publication number
CO2023018191A2
CO2023018191A2 CONC2023/0018191A CO2023018191A CO2023018191A2 CO 2023018191 A2 CO2023018191 A2 CO 2023018191A2 CO 2023018191 A CO2023018191 A CO 2023018191A CO 2023018191 A2 CO2023018191 A2 CO 2023018191A2
Authority
CO
Colombia
Prior art keywords
purification methods
aav vector
column purification
vector column
particles
Prior art date
Application number
CONC2023/0018191A
Other languages
English (en)
Spanish (es)
Inventor
Ohnmar Khanal
Vijesh Kumar
Mi Jin
Original Assignee
Spark Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spark Therapeutics Inc filed Critical Spark Therapeutics Inc
Publication of CO2023018191A2 publication Critical patent/CO2023018191A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/422—Displacement mode
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
CONC2023/0018191A 2021-06-11 2023-12-21 Métodos de purificación de columnas de vectores de aav CO2023018191A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163209680P 2021-06-11 2021-06-11
US202263366094P 2022-06-09 2022-06-09
PCT/US2022/072859 WO2022261663A1 (en) 2021-06-11 2022-06-10 Aav vector column purification methods

Publications (1)

Publication Number Publication Date
CO2023018191A2 true CO2023018191A2 (es) 2024-01-25

Family

ID=84426294

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2023/0018191A CO2023018191A2 (es) 2021-06-11 2023-12-21 Métodos de purificación de columnas de vectores de aav

Country Status (13)

Country Link
US (1) US20240271159A1 (cg-RX-API-DMAC7.html)
EP (1) EP4351755A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024525142A (cg-RX-API-DMAC7.html)
KR (1) KR20240021231A (cg-RX-API-DMAC7.html)
AU (1) AU2022289035A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023025999A2 (cg-RX-API-DMAC7.html)
CA (1) CA3221540A1 (cg-RX-API-DMAC7.html)
CL (2) CL2023003646A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023018191A2 (cg-RX-API-DMAC7.html)
IL (1) IL309070A (cg-RX-API-DMAC7.html)
MX (1) MX2023014809A (cg-RX-API-DMAC7.html)
PE (1) PE20240359A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022261663A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025528182A (ja) * 2022-08-12 2025-08-26 ウルトラジェニックス ファーマシューティカル インコーポレイテッド 完全な組換えアデノ関連性ウイルス粒子から空の粒子を分離するための新規な陰イオン交換クロマトグラフィーの方法
EP4670812A1 (en) * 2024-06-27 2025-12-31 Sartorius Stedim Biotech GmbH CONTINUOUS POLISHING OF VIRAL CAPSIDES
US20260085295A1 (en) * 2024-09-23 2026-03-26 Regeneron Pharmaceuticals, Inc. PARTITIONING ANION EXCHANGE CHROMATOGRAPHY FOR PURIFICATION OF RECOMBINANT ADENO-ASSOCIATED VIRUS (rAAV)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4559429B2 (ja) * 2003-05-21 2010-10-06 ジェンザイム・コーポレーション 空キャプシドを実質的に含まない組換えaavビリオン調製物を生成するための方法
AU2010227419A1 (en) * 2009-03-27 2011-10-20 Proyecto De Biomedicina Cima, S.L. Methods and compositions for the treatment of cirrhosis and liver fibrosis
EP3054006A1 (en) * 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography
EP3658250A4 (en) * 2017-06-30 2021-10-27 Spark Therapeutics, Inc. AAV VECTOR COLUMN CLEANING PROCEDURE
WO2023077085A2 (en) * 2021-10-29 2023-05-04 Oxford Biomedica Solutions Llc Methods and compositions for the purification of adeno-associated virus
JP2025535118A (ja) * 2022-10-11 2025-10-22 メイラグティーエックス ユーケー アイアイ リミティド Aavカプシドの精製のためのクロマトグラフィー方法

Also Published As

Publication number Publication date
US20240271159A1 (en) 2024-08-15
PE20240359A1 (es) 2024-02-27
CA3221540A1 (en) 2022-12-15
JP2024525142A (ja) 2024-07-10
BR112023025999A2 (pt) 2024-02-27
AU2022289035A1 (en) 2024-01-04
IL309070A (en) 2024-02-01
KR20240021231A (ko) 2024-02-16
EP4351755A1 (en) 2024-04-17
EP4351755A4 (en) 2025-04-23
WO2022261663A1 (en) 2022-12-15
CL2023003646A1 (es) 2024-10-25
CL2026000535A1 (es) 2026-06-12
MX2023014809A (es) 2024-01-29

Similar Documents

Publication Publication Date Title
BR112023025999A2 (pt) Métodos de purificação de coluna de vetor de aav
BR112012020254A2 (pt) método para a purificação de anticorpos a partir de uma mistura de proteína e, unidade operacional única.
BR112012009227A2 (pt) métodos e sistemas para purificar neurotoxina botulínica não complexada
NO20076157L (no) Anti-TRKB monoklonale antistoffer og anvendelser derav
BR112012005860A2 (pt) peptídeos isolados do veneno de aranha, e usos dos mesmos
AU2006226733A8 (en) Antibodies against CD38 for treatment of multiple myeloma
BR112012017124A2 (pt) método de modificação polipeptídica para purificação de multímeros polipeptídicos
MX2012011926A (es) Anticuerpos para el tratamiento de infeccion y enfermedad asociadas con clostridium dificile.
WO2013078170A8 (en) Purification of anti-c-met antibodies
AR083611A1 (es) Purificacion de anticuerpos mediante unidad simple de cromatografia de intercambio ionico
BR112014032567A2 (pt) purificação de iduronato-2-sulfatase
BRPI0312521B8 (pt) método para a separação de fibrinogênio de plasminogênio
MX337348B (es) Metodos para purificar virus utilizando cromatografia de permeacion en gel.
CL2021000176A1 (es) Uso de especies gram negativas para tratar la dermatitis atópica
WO2022170008A3 (en) Anti-il1rap antibodies
BR112018074966A2 (pt) anticorpos antagonísticos anti-molécula de orientação repulsiva a (grma) para tratar lesão na medula espinhal e dor
IL182340A0 (en) Method for the isolation of haptoglobin
MX2023002675A (es) Métodos de purificación de proteína en ph alcalino.
ATE466079T1 (de) Nukleinsäure konstrukten, pharmazeutische kompositionen und methoden für die behandlung von krebs
BR112021026247A2 (pt) Métodos para purificação de proteína
BR0207447A (pt) Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina
CY1117906T1 (el) Μεθοδος καθαρισμου για υδατανθρακα απο στρεπτοκοκκο ομαδας α
DE602008002933D1 (de) Als ionenkanalmodulatoren geeignete beta-ketoamidderivate
AR086938A1 (es) Purificacion de anticuerpos por cromatografia de una unica unidad
BR0116704A (pt) Antìgenos de streptococcus pyogenes e fragmentos de dna correspondentes